Rolls-Royce Holdings PLC on Thursday raised its outlook for all of 2025, saying a strong first half showed "our multi-year transformation continues to deliver", despite supply chain difficulties and ...

Deutsche Bank Research cuts Rio Tinto to 'hold' (buy) - price target 5,100 (5,300) pence JPMorgan cuts Rio Tinto price target to 5,450 (5,570) pence - 'overweight' Jefferies raises Rio Tinto price ...

Goodwin PLC - Stoke-on-Trent-based engineering firm - Pretax profit jumps 42% to GBP34.3 million in the financial year to April 30 from GBP24.2 million a year prior. Revenue increases 15% to GBP219.7 ...

While London South East do their best to maintain the high quality of the information displayed on this site, we cannot ...

At 16:00 PM, the FTSE 100 Index was up by 60.33 at 9141.77 points, a movement of 0.66%, showing a modest rise in the market. Taylor Wimpey (TW.) was a heavily traded share, with around £881.2m (0 ...

(Alliance News) - Ceres Power Holdings PLC shares surged on Monday as it said South Korean partner Doosan Corp has started mass market production of fuel cell stacks using Ceres's solid oxide ...

Ishares Asia Pacific Dividend Ucits Etf Usd (acc) is listed on the Euronext Amsterdam trading with ticker code IAPU.AM. It has a market capitalisation of $N/A, with ...

(Alliance News) - Ocean Wilsons Holdings Ltd on Monday said it has agreed the terms for an all-share merger with Hansa Investment Co Ltd that will see the combined firm take on Hansa's name and ...

Super X Ai Technology Ltd is listed on the CBOE trading with ticker code SUPX.US. It has a market capitalisation of -, with approximately 0.00 shares in issue. Over the last year, Super X Ai ...

The Oxford, England-based cell and gene therapy contract development and manufacturing company said it expects to report revenue between GBP70 million and GBP73 million for the six months to the end ...

Copyright 2025 Alliance News Ltd. All Rights Reserved.

GSK will pay USD500 million in upfront fees across the agreements. The total value of success-based development, regulatory and commercial milestone payments to Hengrui Pharma is around USD12 billion, ...